
CASDIN CAPITAL, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | LAB | 77.56M | $100.83M |
![]() | RLAY | 11.34M | $59.20M |
![]() | BLFS | 6.71M | $171.10M |
![]() | PRME | 3.17M | $17.55M |
![]() | WGS | 3.01M | $323.99M |
![]() | RVMD | 2.65M | $123.63M |
![]() | RNA | 1.78M | $77.55M |
![]() | SPRY | 1.60M | $16.08M |
![]() | BEAM | 1.60M | $38.83M |
![]() | GPCR | 1.55M | $43.54M |
![]() | NGNE | 1.30M | $22.45M |
![]() | IPSC | 1.23M | $611.64K |
![]() | ABSI | 973K | $2.96M |
![]() | DNLI | 890K | $12.92M |
![]() | MAZE | 759K | $19.68M |
![]() | PACB | 724K | $926.42K |
![]() | SEPN | 553K | $10.41M |
![]() | ILMN | 525K | $49.86M |
![]() | TNYA | 362K | $586.39K |
![]() | TEM | 294K | $23.74M |

Standard BioTools Inc.
LAB
Shares Held
77.56M
Value
$100.83M

Relay Therapeutics, Inc.
RLAY
Shares Held
11.34M
Value
$59.20M

BioLife Solutions, Inc.
BLFS
Shares Held
6.71M
Value
$171.10M

Prime Medicine, Inc.
PRME
Shares Held
3.17M
Value
$17.55M

GeneDx Holdings Corp.
WGS
Shares Held
3.01M
Value
$323.99M

Revolution Medicines, Inc.
RVMD
Shares Held
2.65M
Value
$123.63M

Avidity Biosciences, Inc.
RNA
Shares Held
1.78M
Value
$77.55M

ARS Pharmaceuticals, Inc.
SPRY
Shares Held
1.60M
Value
$16.08M

Beam Therapeutics Inc.
BEAM
Shares Held
1.60M
Value
$38.83M

Structure Therapeutics Inc.
GPCR
Shares Held
1.55M
Value
$43.54M

Neurogene Inc.
NGNE
Shares Held
1.30M
Value
$22.45M

Century Therapeutics, Inc.
IPSC
Shares Held
1.23M
Value
$611.64K

Absci Corporation
ABSI
Shares Held
973K
Value
$2.96M

Denali Therapeutics Inc.
DNLI
Shares Held
890K
Value
$12.92M

Maze Therapeutics, Inc.
MAZE
Shares Held
759K
Value
$19.68M

Pacific Biosciences of California, Inc.
PACB
Shares Held
724K
Value
$926.42K

Septerna, Inc.
SEPN
Shares Held
553K
Value
$10.41M

Illumina, Inc.
ILMN
Shares Held
525K
Value
$49.86M

Tenaya Therapeutics, Inc.
TNYA
Shares Held
362K
Value
$586.39K

Tempus AI, Inc.
TEM
Shares Held
294K
Value
$23.74M
